Research Analysts Set Expectations for Immunic Q1 Earnings

Chronological Source Flow
Back

AI Fusion Summary

Research analysts at HC Wainwright issued FY2027 earnings estimates for MoonLake Immunotherapeutics, with an analyst forecasting a loss per share of $3.11.
05/03 08:02 defenseworld.net
4 Πηγές
05/03 08:02 defenseworld.net
05/03 08:02 defenseworld.net
05/03 08:18 defenseworld.net
Comments
Loading...
0